Factors associated with cardiac allograft vasculopathy after heart transplantation

Factors associated with cardiac allograft vasculopathy after heart transplantation

Bibliographic Details
Main Authors:	Wioletta Szczurek-Wasilewicz, Michał Hawranek, Michał Skrzypek, Tomasz Hrapkowicz, Mariusz Gąsior, Oliwia Warmusz, Bożena Szyguła-Jurkiewicz
Format:	Article
Language:	English
Published:	Termedia Publishing House 2022-10-01
Series:	Advances in Interventional Cardiology
Subjects:	heart transplantation factors cardiac allograft vasculopathy
Online Access:	https://www.termedia.pl/Factors-associated-with-cardiac-allograft-vasculopathy-after-heart-transplantation,35,48013,1,1.html

Similar Items

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
by: Michał Hawranek, et al.
Published: (2021-12-01)

Cardiac allograft vasculopathy: current review
by: B. L. Mironkov, et al.
Published: (2024-07-01)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
by: Kobashigawa Jon
Published: (2000-12-01)

Multimodality Imaging to Detect Rejection, and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients—An Illustrative Review
by: Bibhuti B. Das, et al.
Published: (2022-07-01)

Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
by: Fernando Bacal, et al.
Published: (2000-11-01)

ASSESSMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CARDIAC ALLOGRAFT VASCULOPATHY DEVELOPMENT
by: V. V. Chestukhin, et al.
Published: (2013-03-01)

Cardiac allograft vasculopathy in heart transplanted recipients: The multivessel study
by: Niels Møller Jensen, BSc, et al.
Published: (2024-02-01)

CLINIC EFFICIENCY OF MYOCARDIAL REVASCULARIZATION FOR CARDIAC ALLOGRAFT VASCULOPATHY
by: B. L. Mironkov, et al.
Published: (2014-12-01)

Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study
by: Helena Bedanova, et al.
Published: (2016-03-01)

Gender aspects of incidence of antibody-mediated rejection and allograft vasculopathy events after heart transplantation
by: N. N. Koloskova, et al.
Published: (2019-05-01)

PREGNANCY-ASSOCIATED PLASMA PROTEIN A (PAPP-A) IN CARDIAC ALLOGRAFT VASCULOPATHY
by: О. P. Shevchenko, et al.
Published: (2011-06-01)

Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities
by: Moaz A. Kamel, et al.
Published: (2024-03-01)

Therapeutic potential role of vitamin C in prevention and control of heart transplant rejection and cardiac allograft vasculopathy. A need for consideration
by: Idd J. Kenedy, et al.
Published: (2023-11-01)

Cardiac allograft vasculopathy outcomes among donation after circulatory death heart transplant recipients
by: Antoinette S. Birs, MD, et al.
Published: (2024-05-01)

The potential of autologous regulatory T cell (Treg) therapy to prevent Cardiac Allograft Vasculopathy (CAV) in paediatric heart transplant recipients
by: Apoorva Aiyengar, et al.
Published: (2024-09-01)

Capabilities of intravascular imaging techniques in the diagnosis of cardiac allograft vasculopathy: Literature review
by: A. Yu. Kolesnikov, et al.
Published: (2024-04-01)

Screening of cardiac allograft vasculopathy in heart transplant patients with coronary computed tomography angiography
by: Ana Filipa Amador, et al.
Published: (2024-02-01)

A Covered Coronary Stent for Acute Perforation after a Percutaneous Coronary Intervention due to Cardiac Allograft Vasculopathy
by: Mario Udovičić, et al.
Published: (2024-01-01)

Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy
by: Nazia Husain, et al.
Published: (2021-11-01)

An agent-based model of cardiac allograft vasculopathy: toward a better understanding of chronic rejection dynamics
by: Elisa Serafini, et al.
Published: (2023-09-01)

Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation
by: Moritz Benjamin Immohr, et al.
Published: (2023-11-01)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
by: Masaki Hirose, et al.
Published: (2023-01-01)

Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging
by: Pooja Prasad, et al.
Published: (2023-10-01)

The Role of Echocardiography in the Management of Heart Transplant Recipients
by: Daniele Masarone, et al.
Published: (2021-12-01)

Intravascular visualization methods in estimating vasculopathy of a transplanted heart
by: S. A. Sakhovsky, et al.
Published: (2019-05-01)

EphB4 monomer inhibits chronic graft vasculopathy in an aortic transplant model
by: John T. Langford, MD, et al.
Published: (2023-01-01)

Ethnic disparity in Israel impacts long-term results after heart transplantation
by: Yael Peled, et al.
Published: (2019-01-01)

Percutaneous coronary intervention for coronary allograft vasculopathy with drug-eluting stent in Indian subcontinent: Issues in diagnosis and management
by: Mohammed Shakawat Alam, et al.
Published: (2020-01-01)

PREDICTIVE SIGNIFICANCE OF ANTI-HLA AUTOANTIBODIES IN HEART TRANSPLANT RECIPIENTS
by: O. P. Shevchenko, et al.
Published: (2014-05-01)

Proteomics early after heart transplantation and relation to coronary intimal changes and prognosis
by: Rasmus Gebauer Dalsgaard, BMSc, et al.
Published: (2024-08-01)

THE EXPERIENCE OF PEDIATRIC HEART TRANSPLANTATION ON NORTH-WEST OF RUSSIAN FEDERATION
by: M. A. Simonenko, et al.
Published: (2018-06-01)

HEART RETRANSPLANTATION
by: R. Sh. Saitgareev, et al.
Published: (2016-06-01)

A minor tweak in transplant surgery protocols alters the cellular landscape of the arterial wall during transplant vasculopathy
by: Laura Mickiewicz, et al.
Published: (2024-04-01)

Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy
by: Yi-Wen Lin, et al.
Published: (2022-05-01)

Metabolic Syndrome and Heart Transplantation: An Underestimated Risk Factor?
by: Sandro Sponga, et al.
Published: (2024-03-01)

Failing Heart Transplants and Rejection—A Cellular Perspective
by: Maria Hurskainen, et al.
Published: (2021-12-01)

Clinicopathological correlations in heart transplantation recipients complicated by death or re-transplantation
by: Michelle M. McDonald, et al.
Published: (2022-11-01)

Elevated Plasma Immunoglobulin Levels Prior to Heart Transplantation Are Associated with Poor Post-Transplantation Survival
by: Patricia van den Hoogen, et al.
Published: (2022-12-01)

Ceruloplasmin, Catalase and Creatinine Concentrations Are Independently Associated with All-Cause Mortality in Patients with Advanced Heart Failure
by: Wiktoria Smyła-Gruca, et al.
Published: (2024-03-01)

KEY FEATURES OF THE INTRAGRAFT MICROENVIRONMENT THAT DETERMINE LONG-TERM SURVIVAL FOLLOWING TRANSPLANTATION
by: Sarah eBruneau, et al.
Published: (2012-04-01)